Tadalafil
Tadalafil is a pharmaceutical drug with 144 clinical trials. Currently 9 active trials ongoing. Historical success rate of 89.1%.
Success Metrics
Based on 106 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
33
Mid Stage
78
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.2%
106 of 123 finished
13.8%
17 ended early
9
trials recruiting
144
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia
Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
Clinical Trials (144)
Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia
Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
Platelet-Rich Plasma With or Without Tadalafil for Erectile Dysfunction
Vasodilator and Exercise Study for DMD (VASO-REx)
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females
Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
PDE5 Inhibitor for Alzheimer's Disease
Comparison of Sequential to Initial Combination Therapy in PAH
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 144